Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244

by Sylwia Ammoun, Natalia Ristic, Cordula Matthies, David A. Hilton, C. Oliver Hanemann
Published 2010-01-01

Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways

by Lu Zhou, Emanuela Ercolano, Sylwia Ammoun, M. Caroline Schmid, Magdalena A. Barczyk, Clemens Oliver Hanemann
Published 2011-12-01

Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas

by Agbolahan A Sofela, David A Hilton, Sylwia Ammoun, Daniele Baiz, Claire L Adams, Emanuela Ercolano, Michael D Jenkinson, Kathreena M Kurian, Mario Teo, Peter C Whitfield, Felix Sahm, C Oliver Hanemann
Published 2021-01-01